Stéphane Depil

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 04, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.

Paola Bonaventura, Audrey Page, Olivier Tabone

|Nov 23, 2024
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Donia Hidaoui, Audrey Porquet, Rabie Chelbi

|Oct 10, 2024
Endogenous retroelements in hematological malignancies: From epigenetic dysregulation to therapeutic targeting.

Mohamed Chour, Françoise Porteu, Stéphane Depil

|Mar 05, 2024
Development of NK cell-based cancer immunotherapies through receptor engineering.

Audrey Page, Nicolas Chuvin, Jenny Valladeau-Guilemond

|Feb 15, 2023
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives.

Estelle Baulu, Célia Gardet, Nicolas Chuvin

|Jan 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.

Paola Bonaventura, Vincent Alcazer, Virginie Mutez

Pageof 2

Frequent Collaborators

3 joint publications

Vincent Alcazer

2 joint publications

Nicolas Chuvin

2 joint publications

Françoise Porteu

1 joint publications

L Poirot